Atlas Trials

Hospital General de México Dr. Eduardo Liceaga

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hospital General de México Dr. Eduardo Liceaga

RecordFirmDate
Types of Photoplethysmographic Waves in Adult Patients with Septic Shock (NCT06786364)Hospital General de México Dr. Eduardo Liceaga2024-11-01
Orotracheal Intubation with the ORION Videolaryngoscope Versus the King Vision Videolaryngoscope in Adult Patients: ORION Trial (NCT06622538)Hospital General de México Dr. Eduardo Liceaga2024-10-01
Evaluation of Cognitive Improvement After Bariatric Surgery Using a Virtual Reality Program and the Neuropsi Neuropsychological Battery (NCT07229924)Hospital General de México Dr. Eduardo Liceaga2024-06-25
Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole (NCT06318104)Hospital General de México Dr. Eduardo Liceaga2024-04-19
Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults (NCT04475991)Hospital General de México Dr. Eduardo Liceaga2021-07-13
Clinical Trial Comparing the Self-test for Cervicovaginal Sample Versus Samples From Service Provider (Xyto-Ro) (NCT04520464)Hospital General de México Dr. Eduardo Liceaga2020-10-01
Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial (NCT03923933)Hospital General de México Dr. Eduardo Liceaga2019-06-18
Probiotics on Body Composition and Insulin Resistance in Patients With Obesity and Its Association With Gut Microbiota (NCT04086173)Hospital General de México Dr. Eduardo Liceaga2018-03-01
Non-caloric Sweeteners Levels in Breast Milk and Newborn's Blood and Effect on Microbiota's Composition. (NCT03912038)Hospital General de México Dr. Eduardo Liceaga2018-01-26
Structured Exercise Prescription Program in Obese Children (NCT03552367)Hospital General de México Dr. Eduardo Liceaga2017-12-01

Track Hospital General de México Dr. Eduardo Liceaga automatically

Every clearance here is in the API, with alerts when new ones post.